849094-18-4 Usage
Uses
Used in Medicinal Chemistry:
L-Cysteine, S-(cyclopropylmethyl)-N-[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]is used as a chemical compound in medicinal chemistry for its potential biological activities and unique structure. The exploration of its pharmacological properties and therapeutic uses is an area of ongoing research.
Used in Pharmaceutical Development:
In the pharmaceutical industry, L-Cysteine, S-(cyclopropylmethyl)-N-[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]is used as a starting material or intermediate in the synthesis of new drugs. Its unique structural features may contribute to the development of innovative therapeutic agents with novel mechanisms of action.
Used in Biochemical Research:
L-Cysteine, S-(cyclopropylmethyl)-N-[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]is utilized in biochemical research to study its interactions with biological systems and to understand its potential role in various biological processes. This knowledge can aid in the discovery of new targets for drug development and the elucidation of disease mechanisms.
Check Digit Verification of cas no
The CAS Registry Mumber 849094-18-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,0,9 and 4 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 849094-18:
(8*8)+(7*4)+(6*9)+(5*0)+(4*9)+(3*4)+(2*1)+(1*8)=204
204 % 10 = 4
So 849094-18-4 is a valid CAS Registry Number.
849094-18-4Relevant academic research and scientific papers
CATHEPSIN INHIBITORS FOR THE TREATMENT OF BONE CANCER AND BONE CANCER PAIN
-
, (2012/11/13)
The present invention is directed to methods of using compounds that are inhibitors of cysteine proteases, in particular, of both cathepsins S and K and optionally further cathepsins B and/or L in treating bone cancer. The present invention is directed to pharmaceutical compositions comprising these compounds for treating bone cancer and bone cancer pain, especially the pain associated with metastasis. A single compound can be used to ameliorate the pain, the injury to bone, while also reducing tumor growth, the risk of metastasis and/or invasiveness of the cancer.
HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS
-
Page/Page column 93-94, (2008/06/13)
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
